Balanced Health Products expands its voluntary recall of StarCaps Diet Systemto include additional lots - numbers 12/2009-82866 and 12/2010-8301 - because the capsules in the 30-count bottles contain the undeclared ingredient bumetanide, a diuretic that can cause serious fluid and electrolyte loss. The firm says in a Dec. 8 release it believes an additional lot of raw material was contaminated with bumetanide in Lima, Peru. The company suspended StarCaps shipments after National Football League players alleged the product contained bumetanide, which can mask steroid use (1"The Tan Sheet" Nov. 3, 2008, In Brief)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
At Medicines for Europe’s legal and annual conferences in Brussels last week, multiple key issues competed for attention, giving the generics and biosimilars industry plenty to think about at a critical time for EU pharma reform.
The creation of a single national formulary for medicines prescribing that could impact industry is among the action points in the UK government’s new 10-year health plan for the National Health Service in England.